HAS Healthcare Advanced Synthesis, previously known as Helsinn Advanced Synthesis SA, specializes in the development and production of Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs), and anticancer compounds for external clients from the clinical phase to commercial supply, on an exclusive basis. The manufacturing facility, established in 1984, is situated in Biasca, Switzerland. The Biasca site undergoes regular inspections by the FDA, SwissMedic, and other global regulatory authorities. Production capacities span from small-scale to large-scale, ranging from grams to tens of kilograms. HAS Healthcare Advanced Synthesis is dedicated to delivering a dependable, top-notch, and customized service as a comprehensive CDMO provider.
Products & Services
Aloxi Palonosetron HCl Injection 0.25mg
Anamorelin Hydrochloride
Bexarotene
Carfilzomib
Sites
HAS Healthcare Advanced Synthesis SA
Audited
Country
SwitzerlandCity
Biasca
Address
Via Industria 24, 6710